Nothing Special   »   [go: up one dir, main page]

DK63683A - Fremgangsmaade til fremstilling af cephemderivater - Google Patents

Fremgangsmaade til fremstilling af cephemderivater Download PDF

Info

Publication number
DK63683A
DK63683A DK63683A DK63683A DK63683A DK 63683 A DK63683 A DK 63683A DK 63683 A DK63683 A DK 63683A DK 63683 A DK63683 A DK 63683A DK 63683 A DK63683 A DK 63683A
Authority
DK
Denmark
Prior art keywords
cephemer
derivatives
procedure
production
cephemer derivatives
Prior art date
Application number
DK63683A
Other languages
English (en)
Other versions
DK63683D0 (da
Inventor
Takao Takaya
Hisashi Takasugi
Toshiyuki Chiba
Kiyoshi Tsuji
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Publication of DK63683D0 publication Critical patent/DK63683D0/da
Publication of DK63683A publication Critical patent/DK63683A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/22—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with radicals containing only hydrogen and carbon atoms, attached in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/08—1,2,4-Thiadiazoles; Hydrogenated 1,2,4-thiadiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/06—1,2,3-Thiadiazoles; Hydrogenated 1,2,3-thiadiazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/10—1,2,5-Thiadiazoles; Hydrogenated 1,2,5-thiadiazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK63683A 1982-03-08 1983-02-14 Fremgangsmaade til fremstilling af cephemderivater DK63683A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/355,339 US4464369A (en) 1977-03-14 1982-03-08 7-Acylamino-3-cephem-4-carboxylic acid derivatives and pharmaceutical compositions

Publications (2)

Publication Number Publication Date
DK63683D0 DK63683D0 (da) 1983-02-14
DK63683A true DK63683A (da) 1983-09-09

Family

ID=23397090

Family Applications (1)

Application Number Title Priority Date Filing Date
DK63683A DK63683A (da) 1982-03-08 1983-02-14 Fremgangsmaade til fremstilling af cephemderivater

Country Status (7)

Country Link
US (1) US4464369A (da)
EP (1) EP0088385A3 (da)
JP (1) JPS58164594A (da)
KR (1) KR840004113A (da)
CA (1) CA1197234A (da)
DK (1) DK63683A (da)
ES (1) ES520364A0 (da)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4609730A (en) * 1982-11-22 1986-09-02 Fujisawa Pharmaceutical Co., Ltd. 7-[substituted imino-2-(2-aminothiazol-4-yl)-acetamido]-3(2,2-dihalovinyl or ethynyl)-3-cephem-4-carboxylic acid (syn isomers), having antimicrobial activities
US4874856A (en) * 1985-06-24 1989-10-17 Bristol-Myers Company 3-(substituted)propenyl-7-(aminothiazolylacetamido) ceph-3-em-4-carboxylic acids and esters thereof
US4708955A (en) * 1985-06-24 1987-11-24 Bristol-Myers Company 3-(substituted)propenyl-7-aminothiazol-ylcephalosporanic acids and esters thereof
CA2517722C (en) * 2003-03-10 2008-05-20 Diebold, Incorporated Cash dispensing automated banking machine deposit accepting system and method
CN101153045B (zh) * 2006-09-30 2010-06-02 山东轩竹医药科技有限公司 新型头孢菌素化合物
CN103945842A (zh) 2011-09-09 2014-07-23 丘比斯特药物股份有限公司 治疗肺内感染的方法
US8809314B1 (en) 2012-09-07 2014-08-19 Cubist Pharmacueticals, Inc. Cephalosporin compound
US8476425B1 (en) 2012-09-27 2013-07-02 Cubist Pharmaceuticals, Inc. Tazobactam arginine compositions
US20140274997A1 (en) 2013-03-15 2014-09-18 Cubist Pharmaceuticals, Inc. Cephalosporin pharmaceutical compositions
US20140274994A1 (en) 2013-03-15 2014-09-18 Cubist Pharmaceuticals, Inc. Stabilizing ceftolozane
US9872906B2 (en) 2013-03-15 2018-01-23 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
EP3043797B1 (en) 2013-09-09 2020-04-08 Merck Sharp & Dohme Corp. Treating infections with ceftolozane/tazobactam in subjects having impaired renal function
US20150094293A1 (en) 2013-09-27 2015-04-02 Calixa Therapeutics, Inc. Solid forms of ceftolozane
CN106866704B (zh) * 2017-02-08 2019-06-14 河北科技大学 催化氢化脱除对硝基苄酯以制备7-acca的方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3971778A (en) * 1972-05-12 1976-07-27 Glaxo Laboratories Limited Cephalosporins having (α-etherified oximino)acylamido groups at the 7-position
GB1592149A (en) * 1976-10-08 1981-07-01 Fujisawa Pharmaceutical Co 3 7-disubstituted-3-cephem-4-carboxylic acid compounds and processes for preparation thereof
PH17188A (en) * 1977-03-14 1984-06-14 Fujisawa Pharmaceutical Co New cephem and cepham compounds and their pharmaceutical compositions and method of use
US4399133A (en) * 1977-03-14 1983-08-16 Fujisawa Pharmaceutical Company, Limited Cephem compounds
FR2387235A1 (fr) * 1978-01-23 1978-11-10 Fujisawa Pharmaceutical Co Procede de preparation de composes d'acide 3,7-disubstitue-3-cephem-4-carboxylique et nouveaux produits ainsi obtenus, ayant une forte activite antibacterienne
GB2025933B (en) * 1978-06-13 1982-10-27 Fujisawa Pharmaceutical Co Cephem and cepham compounds
ZA806977B (en) * 1979-11-19 1981-10-28 Fujisawa Pharmaceutical Co 7-acylamino-3-vinylcephalosporanic acid derivatives and processes for the preparation thereof

Also Published As

Publication number Publication date
US4464369A (en) 1984-08-07
EP0088385A2 (en) 1983-09-14
ES8404360A1 (es) 1984-04-16
ES520364A0 (es) 1984-04-16
CA1197234A (en) 1985-11-26
EP0088385A3 (en) 1984-12-05
JPS58164594A (ja) 1983-09-29
DK63683D0 (da) 1983-02-14
KR840004113A (ko) 1984-10-06
JPH0526792B2 (da) 1993-04-19

Similar Documents

Publication Publication Date Title
DK301383D0 (da) Fremgangsmade til fremstilling af imidazolderivater
DK2281A (da) Fremgangsmaade til fremstilling af tiazolinderivater
DK300981A (da) Fremgangsmaade til fremstilling af imidazolderivater
DK95483A (da) Fremgangsmaade til fremstilling af tetrahydropyranderivater
DK161581A (da) Fremgangsmaade til fremstilling af imidazolderivater
DK100281A (da) Fremgangsmaade til fremstilling af imidazolderivater
DK241883D0 (da) Fremgangsmade til fremstilling af 1-sulfo-2-oxoazetidinderivater
DK276582A (da) Fremgangsmaade til fremstilling af cephemderivater
DK372283A (da) Fremgangsmaade til fremstilling af desoxyuridinderivater
DK63683A (da) Fremgangsmaade til fremstilling af cephemderivater
DK335882A (da) Fremgangsmaade til fremstilling af cephemderivater
DK323083D0 (da) Fremgangsmade til fremstilling af 19-thio-androstanderivater
DK427083A (da) Fremgangsmaade til fremstilling af cephemderivater
DK435483D0 (da) Fremgangsmade til fremstilling af fenylcyklobutylderivater
DK172181A (da) Fremgangsmaade til fremstilling af 9-carbamoyl-9-aminoalkylfluoren-derivater
DK261883D0 (da) Fremgangsmade til fremstilling af prostaglandin-d-derivater
DK162230C (da) Fremgangsmaade til fremstilling af 2-thiacephemderivater
DK426683D0 (da) Fremgangsmade til fremstilling af oxacephalosporinderivater
DK317283A (da) Fremgangsmaade til fremstilling af thiadiazolderivater
DK340483D0 (da) Fremgangsmade til fremstilling af fluoralkylerede carbapenemderivater
DK482983A (da) Fremgangsmaade til fremstilling af phenylderivater
DK165583D0 (da) Fremgangsmade til fremstilling af furanderivater
DK268981A (da) Fremgangsmaade til fremstilling af adeninnucleosidderivater
DK542383D0 (da) Fremgangsmade til fremstilling af acridanonderivater
DK296883D0 (da) Fremgangsmade til fremstilling af eburnanoximaetere

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment